NEVOVIV H-5/12.5 — Nebivolol Hydrochloride 5 mg + Hydrochlorothiazide 12.5 mg Tablets

Overview

NEVOVIV H-5/12.5 is a combination antihypertensive medication containing Nebivolol Hydrochloride 5 mg and Hydrochlorothiazide 12.5 mg. This formulation is designed to provide comprehensive blood pressure management, effectively reducing hypertension and lowering the risk of heart attack, stroke, and kidney complications.

• Nebivolol Hydrochloride is a beta-1 selective blocker that reduces heart rate and cardiac workload.

• Hydrochlorothiazide (HCTZ) is a thiazide diuretic that promotes the excretion of excess sodium and water.

Together, they provide dual-action blood pressure control for patients requiring enhanced antihypertensive therapy.

Composition

Each tablet contains:

• Nebivolol Hydrochloride 5 mg – Beta-1 selective blocker that decreases heart rate, cardiac output, and blood pressure.

• Hydrochlorothiazide 12.5 mg – Thiazide diuretic that reduces fluid retention and decreases blood volume.

Dosage Form

• Tablet

Therapeutic Class

• Antihypertensive / Beta-Blocker + Diuretic Combination

Indications

NEVOVIV H-5/12.5 Tablets are indicated for:

• Management of hypertension (high blood pressure)

• Patients requiring combination therapy for optimal blood pressure control

• Reduction of cardiovascular risk, including heart attack and stroke

• Prevention of hypertension-related kidney complications

Mechanism of Action

• Nebivolol Hydrochloride selectively blocks beta-1 adrenergic receptors, reducing heart rate and cardiac output, thereby lowering blood pressure.

• Hydrochlorothiazide promotes excretion of sodium and water, decreasing blood volume and vascular resistance.

• The combination provides synergistic antihypertensive effects, addressing both cardiac workload and fluid retention.

Dosage and Administration

• Recommended Dose: As prescribed by the physician, usually once daily

• Route: Oral

• Duration: Long-term therapy as advised by a healthcare provider

Note: Regular monitoring of blood pressure, electrolytes, and kidney function is recommended.

Benefits

• Provides dual-action blood pressure control

• Reduces risk of heart attack, stroke, and kidney disease

• Suitable for patients uncontrolled by monotherapy

• Convenient once-daily dosing enhances adherence

Side Effects

NEVOVIV H-5/12.5 is generally well tolerated. Possible side effects include:

• Dizziness or lightheadedness

• Fatigue or tiredness

• Headache

• Increased urination

• Rarely, electrolyte imbalances or hypotension

Consult your physician if side effects persist or worsen.

Precautions

• Avoid use in pregnancy

• Use with caution in renal or liver impairment

• Inform your doctor about other medications to prevent drug interactions

• Regular monitoring of blood pressure, electrolytes, and kidney function is advised

Storage

Store below 25°C, in a dry place away from sunlight. Keep out of reach of children.

Key Product Information

• Brand Name: NEVOVIV H-5/12.5

• Composition: Nebivolol Hydrochloride 5 mg + Hydrochlorothiazide 12.5 mg

• Dosage Form: Tablet

• Therapeutic Class: Antihypertensive / Beta-Blocker + Diuretic

• Manufacturer: [Insert Company Name]

• Packaging: [Example: 10×10 Tablets / Strip]

Why Choose NEVOVIV H-5/12.5

• Provides effective dual-action blood pressure management

• Helps maintain healthy heart and kidney function

• Convenient once-daily tablet

• Manufactured under strict GMP-certified quality standards

Conclusion

NEVOVIV H-5/12.5 (Nebivolol Hydrochloride 5 mg + Hydrochlorothiazide 12.5 mg Tablets) delivers safe and effective management of hypertension. By combining a beta-blocker and diuretic, it helps control blood pressure, protect cardiovascular health, and prevent kidney complications, supporting long-term wellness.